Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2025-06-02 2025-07-02 259058
SANDOZ AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2020-03-18 2020-06-15 108901
SANDOZ AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2023-10-10 2023-10-24 206684
SANDOZ AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2023-11-20 2024-01-03 210832
SANDOZ AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2021-08-09 2021-08-23 143847
SANDOZ AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2025-11-17 2026-01-08 272006
SANDOZ AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2024-07-02 2024-08-06 231741
SANDOZ ANAGRELIDE 0.5MG CAPSULE Resolved 2020-01-08 2023-11-17 102534
SANDOZ ANAGRELIDE 0.5MG CAPSULE Resolved 2018-05-07 2018-09-10 48791
SANDOZ ANAGRELIDE 0.5MG CAPSULE Resolved 2017-07-24 2017-09-06 16716
SANDOZ ANASTROZOLE 1MG TABLET Resolved 2021-04-12 2021-04-20 137306
SANDOZ ANASTROZOLE 1MG TABLET Resolved 2017-05-08 2017-05-15 9454
SANDOZ APIXABAN SDZ 2.5MG TABLET Resolved 2024-10-15 2024-10-22 240291
SANDOZ APIXABAN SDZ 5MG TABLET Resolved 2026-03-02 2026-03-24 279251
SANDOZ APIXABAN SDZ 5MG TABLET Resolved 2025-04-14 2025-05-06 254985
SANDOZ APIXABAN SDZ 5MG TABLET Resolved 2026-03-02 2026-03-24 279254
SANDOZ APIXABAN SDZ 5MG TABLET Resolved 2024-12-10 2025-01-21 245202
SANDOZ APIXABAN SDZ 5MG TABLET Resolved 2025-12-08 2025-12-15 273753
SANDOZ APIXABAN SDZ 2.5MG TABLET Resolved 2025-10-27 2026-01-09 270344
SANDOZ APIXABAN SDZ 2.5MG TABLET Resolved 2025-02-24 2025-04-22 251107
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136